Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42


Reproductive Neuroendocrine Pathways of Social Behavior.

Parhar IS, Ogawa S, Ubuka T.

Front Endocrinol (Lausanne). 2016 Mar 31;7:28. doi: 10.3389/fendo.2016.00028. eCollection 2016. Review.


Neuronal correlates of depression.

Chaudhury D, Liu H, Han MH.

Cell Mol Life Sci. 2015 Dec;72(24):4825-48. doi: 10.1007/s00018-015-2044-6. Epub 2015 Nov 5. Review.


Neurotransmitter Systems in a Mild Blast Traumatic Brain Injury Model: Catecholamines and Serotonin.

Kawa L, Arborelius UP, Yoshitake T, Kehr J, Hökfelt T, Risling M, Agoston D.

J Neurotrauma. 2015 Aug 15;32(16):1190-9. doi: 10.1089/neu.2014.3669. Epub 2015 Apr 1.


Antidepressant effects of resveratrol in an animal model of depression.

Hurley LL, Akinfiresoye L, Kalejaiye O, Tizabi Y.

Behav Brain Res. 2014 Jul 15;268:1-7. doi: 10.1016/j.bbr.2014.03.052. Epub 2014 Apr 6.


Molecular imaging as a guide for the treatment of central nervous system disorders.

Kim E, Howes OD, Kapur S.

Dialogues Clin Neurosci. 2013 Sep;15(3):315-28. Review.


Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunction.

Pehrson AL, Sanchez C.

CNS Spectr. 2014 Apr;19(2):121-33. doi: 10.1017/S1092852913000540. Epub 2013 Aug 1. Review.


Mapping anhedonia onto reinforcement learning: a behavioural meta-analysis.

Huys QJ, Pizzagalli DA, Bogdan R, Dayan P.

Biol Mood Anxiety Disord. 2013 Jun 19;3(1):12. doi: 10.1186/2045-5380-3-12.


The association of interoceptive awareness and alexithymia with neurotransmitter concentrations in insula and anterior cingulate.

Ernst J, Böker H, Hättenschwiler J, Schüpbach D, Northoff G, Seifritz E, Grimm S.

Soc Cogn Affect Neurosci. 2014 Jun;9(6):857-63. doi: 10.1093/scan/nst058. Epub 2013 Apr 16.


Somatic drugs for psychiatric diseases: aspirin or simvastatin for depression?

Rahola JG.

Curr Neuropharmacol. 2012 Jun;10(2):139-58. doi: 10.2174/157015912800604533.


Antidepressant effect of geranylgeranylacetone in a chronic mild stress model of depression and its possible mechanism.

Zhong JM, Wu SY, Bai J, Guo Q, Tao J, Chen H, Zhao NW, Zhao Z, Fu H.

Exp Ther Med. 2012 Oct;4(4):627-632. Epub 2012 Aug 16.


Sweet success, bitter defeat: a taste phenotype predicts social status in selectively bred rats.

Eaton JM, Dess NK, Chapman CD.

PLoS One. 2012;7(10):e46606. doi: 10.1371/journal.pone.0046606. Epub 2012 Oct 3. Erratum in: PLoS One. 2013;8(8). doi:10.1371/annotation/980a13fe-34d4-4d8a-89ee-65fa88703fcd.


Is there anything really novel on the antidepressant horizon?

Murrough JW, Charney DS.

Curr Psychiatry Rep. 2012 Dec;14(6):643-9. doi: 10.1007/s11920-012-0321-8. Review.


PI3K/Akt signaling pathway in the basolateral amygdala mediates the rapid antidepressant-like effects of trefoil factor 3.

Shi HS, Zhu WL, Liu JF, Luo YX, Si JJ, Wang SJ, Xue YX, Ding ZB, Shi J, Lu L.

Neuropsychopharmacology. 2012 Nov;37(12):2671-83. doi: 10.1038/npp.2012.131. Epub 2012 Jul 25.


The neurobiology of depression--revisiting the serotonin hypothesis. I. Cellular and molecular mechanisms.

Albert PR, Benkelfat C, Descarries L.

Philos Trans R Soc Lond B Biol Sci. 2012 Sep 5;367(1601):2378-81. doi: 10.1098/rstb.2012.0190.


Ketamine for depression: where do we go from here?

Aan Het Rot M, Zarate CA Jr, Charney DS, Mathew SJ.

Biol Psychiatry. 2012 Oct 1;72(7):537-47. doi: 10.1016/j.biopsych.2012.05.003. Epub 2012 Jun 16. Review.


Antidepressant-like effects of low ketamine dose is associated with increased hippocampal AMPA/NMDA receptor density ratio in female Wistar-Kyoto rats.

Tizabi Y, Bhatti BH, Manaye KF, Das JR, Akinfiresoye L.

Neuroscience. 2012 Jun 28;213:72-80. doi: 10.1016/j.neuroscience.2012.03.052. Epub 2012 Apr 19.


Drug development in pediatric psychiatry: current status, future trends.

March JS, Fegert JM.

Child Adolesc Psychiatry Ment Health. 2012 Feb 7;6:7. doi: 10.1186/1753-2000-6-7. No abstract available.


Ketamine for treatment-resistant unipolar depression: current evidence.

Mathew SJ, Shah A, Lapidus K, Clark C, Jarun N, Ostermeyer B, Murrough JW.

CNS Drugs. 2012 Mar 1;26(3):189-204. doi: 10.2165/11599770-000000000-00000. Review.


The neurobiology of anhedonia and other reward-related deficits.

Der-Avakian A, Markou A.

Trends Neurosci. 2012 Jan;35(1):68-77. doi: 10.1016/j.tins.2011.11.005. Epub 2011 Dec 15. Review.

Items per page

Supplemental Content

Write to the Help Desk